Literature DB >> 19055167

A "hyperextensive" review of Ehlers-Danlos syndrome.

Neil F Fernandes1, Robert A Schwartz.   

Abstract

Ehlers-Danlos syndrome (EDS) is a heterogeneous group of connective tissue disorders characterized by hyperextensibility, delayed wound healing, joint hypermobility, thin skin, easy bruising, tissue fragility, "cigarette-paper" scarring over bony prominences, mitral valve prolapse, and other findings. There are 6 main types of EDS. Regardless of presentation as a chief concern or an incidental finding, physicians should be aware that the prominent skin findings of EDS are cutaneous signs of an important systemic disorder.

Entities:  

Mesh:

Year:  2008        PMID: 19055167

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  5 in total

Review 1.  Risk factors for the development of degenerative cervical myelopathy: a review of the literature.

Authors:  Guillaume Baucher; Jelena Taskovic; Lucas Troude; Granit Molliqaj; Aria Nouri; Enrico Tessitore
Journal:  Neurosurg Rev       Date:  2021-11-30       Impact factor: 3.042

2.  Mitral valve prolapse and the association with cutaneous mucin infiltration: ("cardiocutaneous mucinosis").

Authors:  Uzma Farooq; Sonal Choudhary; Michael P McLeod; Daniele Torchia; Paolo Romanelli
Journal:  J Clin Aesthet Dermatol       Date:  2013-05

3.  Non-operative management of diverticular perforation in a patient with suspected Ehlers-Danlos syndrome.

Authors:  M C Casey; I Robertson; P S Waters; J Hanaghan; W Khan; K Barry
Journal:  Int J Surg Case Rep       Date:  2014-01-08

Review 4.  Severe aortopathy due to fibulin-4 deficiency: molecular insights, surgical strategy, and a review of the literature.

Authors:  Camden Hebson; Karlene Coleman; Martha Clabby; Denver Sallee; Suma Shankar; Bart Loeys; Lut Van Laer; Brian Kogon
Journal:  Eur J Pediatr       Date:  2013-11-26       Impact factor: 3.183

5.  Wound dressings - a review.

Authors:  Selvaraj Dhivya; Viswanadha Vijaya Padma; Elango Santhini
Journal:  Biomedicine (Taipei)       Date:  2015-11-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.